Diseases [C] » Infections [C01] » Parasitic Diseases » Protozoan Infections » Malaria » Malaria, Falciparum
Diseases [C] » Infections [C01] » Vector Borne Diseases » Malaria » Malaria, Falciparum
Description
Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. MeSH
Hierarchy View
Subtype Terms (1)
Approved Indicated Drugs (5)
Phase 4 Indicated Drugs (20)
Phase 2 Indicated Drugs (21)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (67)
Infectious Disease Institute, Kampala, Uganda
Institute of Tropical Medicine, Belgium
Instituto Nacional de Salud. Peru
Kenya Medical Research Institute
Kumasi Centre for Collaborative Research
Kwame Nkrumah University of Science and Technology
Malaria Research and Training Center, Bamako, Mali
Malaria Research Capacity Development in West and Central Africa Consortium
National Center for Parasitology, Entomology and Malaria Control
National Centre for Parasitology, Entomology and Malaria Control, Cambodia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Medical Research, Tanzania
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Malariology, Parasitology and Entomology, Vietnam
National Institutes of Health (NIH)
School of Medical Sciences Kumasi
Organization Involved with Phase 3 Indications (38)
Cambodia National Malaria Control Programme
Centro Internacional de Entrenamiento e Investigaciones Médicas
Chinese Academy of Medical Sciences
Department of Medical Research, Lower Myanmar
European and Developing Countries Clinical Trials Partnership (EDCTP)
Groupement de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
HealthNet International, Peshawar, Pakistan
Hôpital Général de Référence St Luc, Kisantu, DR Congo
Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO)
Organization Involved with Phase 2 Indications (54)
Asociación Civil Selva Amazónica
Bethesda Hospital, Tomohon, North Sulawasi, Indonesia
Centre de Recerca en Salut Internacional de Barcelona, Spain.
Centre de Recherche en Sante de Nouna, Burkina Faso
Centre de Recherche Médicale de Lambaréné
District Hospital Bagamoyo, Dar es Salaam, Tanzania
International Center for Diarrheal Disease Research
Kivunge Public Health Care Center, Zanzibar, Tanzania
Malaria Research Center, Rourkela, India
Manica's health Research Centre, centre de investigacao Saude-Manica (CISM)
Organization Involved with Phase 1 Indications (31)
Biomedical Primate Research Centre
Centre National de Recherche et de Formation sur la Paludisme, Ouagadougou, Burkina Faso
Charles Mérieux Center for Infectious Disease, Mali
Clinical Neuroscience Solutions, Inc.
Comprehensive Clinical Development, Inc.
German Federal Ministry of Education and Research
Hammersmith Medicines Research
Institut National de la Santé Et de la Recherche Médicale, France
Organization Involved with Other Experimental Indications (22)
Armed Forces Research Institute of Medical Sciences, Thailand
Bill and Melinda Gates Foundation
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.